← 24 Aug 2026 · Short-term Top 10 — Health Care
Short-term Top 10 — Health Care — what changed on 25 Aug 2026
A dated record of one session: what entered or left, what moved inside the ten and by how much, who is closest to the boundary, and how the list did against its benchmark. Each bar is a percentile: how this company ranked against every company the score ranked, 0–100.
The short-term score is a published weighted sum of percentile ranks, rebalanced every Monday. A list is a published formula and its output, not a recommendation. Method version 3.
Get this list's changes by email
Who entered, who left, and the reason — with the score moves behind it.
Informational only — not financial advice. The daily email has not started yet — subscribing now puts you on the list for the first one. Unsubscribe in one click.
Membership
No company entered or left on 25 Aug 2026. The next scheduled change is at this list's next rebalance.
Inside the ten
Against the previous session, 24 Aug 2026.
| Company | Rank | Score | Pillar that moved most |
|---|---|---|---|
| GLAUKOS CORP (GKOS) | 1 +3 | 71.7 +1.5 | Setup 48th → 53rd |
| HINGE HEALTH INC CLASS A (HNGE) | 2 | 71.7 +0.1 | Volume and participation 97th → 94th |
| Moderna (MRNA) | 3 +6 | 70.3 +4.3 | Volume and participation 51st → 83rd |
| DEFINIUM THERAPEUTICS INC (DFTX) | 4 +2 | 69.8 +0.3 | Volume and participation 77th → 62nd |
| IMMUNOME INC (IMNM) | 5 | 69.6 0.0 | Volume and participation 48th → 50th |
| KINIKSA PHARMACEUTICALS INTERNATIO (KNSA) | 13 −5 | 66.1 −0.3 | Momentum 58th → 55th |
| Revolution Medicines (RVMD) | 16 −9 | 65.4 −2.8 | Volume and participation 65th → 53rd |
| NUVATION BIO INC CLASS A (NUVB) | 25 −15 | 63.7 −2.3 | Volume and participation 59th → 44th |
| Merck & Co. (MRK) | 40 −39 | 60.9 −11.2 | Momentum 54th → 49th |
| ZENAS BIOPHARMA INC (ZBIO) | 90 −87 | 54.7 −16.6 | Setup 92nd → 71st |
At the edge
Knocking
- Veeva Systems (VEEV) scores 14.6 above the lowest member — the sector cap, not the score, is what is keeping it out
- LIFESTANCE HEALTH GROUP INC (LFST) scores 14.6 above the lowest member — the sector cap, not the score, is what is keeping it out
Closest to the exit
- NUVATION BIO INC CLASS A (NUVB) 2.1 below the score at rank 15, where the hold band ends
- Merck & Co. (MRK) 4.9 below the score at rank 15, where the hold band ends
- ZENAS BIOPHARMA INC (ZBIO) 11.1 below the score at rank 15, where the hold band ends
Ranked against 239 eligible Health Care companies on this session. A company at the edge is a company near a boundary, not a prediction that it will cross one.
Against the benchmark
SPY is the S&P 500 ETF — the US large-cap market average.
+3.2% since the previous session (2026-08-24), against +0.3% for SPY — 2.9 points ahead of the benchmark. Tracked since 2026-08-18.
+3.3% since 2026-08-18, against −0.2% for SPY — 3.5 points ahead of the benchmark. Tracked since 2026-08-18.
Both curves are total return through 25 Aug 2026: a distribution buys more of the company that paid it, on the benchmark as much as on the list.
More
Informational only — NOT financial advice.